Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Validation of the Hebrew Version of the Montreal Affective Voices.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01512732
Recruitment Status : Unknown
Verified January 2012 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : January 19, 2012
Last Update Posted : January 24, 2012
Information provided by (Responsible Party):
Hadassah Medical Organization

Brief Summary:
Today, no non-verbal auditory stimuli that assess mental processing are available in Israel. The goal of this study is to make available a validated set of auditory stimuli in Israel. We created a computerized Hebrew version of the Montreal Affective Voices (MAV). The MAV is a novel tool for assessing mental processing. The MAV consists of 90 nonverbal affect bursts corresponding to nine different emotions (such as anger, fear, happiness etc.) recorded by ten different actors. The uniqueness of these affective bursts is that they do not contain verbal context, but rather express affective moods using the vowel /a/ (as in "apple"). In this study, the investigators will verify the new Hebrew version of MAV in healthy control groups. Next, the investigators will compare the mental processing ability in young vs. old population, using the MAV test. In addition, the investigators will assess mental processing in two pathologic study groups (Parkinson's disease, major depressive disorder) using the MAV test. The investigators intend to use the MAV tool in future research in Parkinson's disease and depression.

Condition or disease
Parkinson's Disease Depression

Layout table for study information
Study Type : Observational
Estimated Enrollment : 120 participants
Study Start Date : February 2012

Resource links provided by the National Library of Medicine

healthy control group
Young (20-49) and Older (50-70) healthy group (n=60)
Parkinson's disease patients
Major depressive disorder patients

Primary Outcome Measures :
  1. Verifying the results achieved by Belin et al (2008) when using the Hebrew version of the MAV bursts in healthy control groups. [ Time Frame: 12 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   20 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
healthy group, Parkinson's disease patients, Major depressive disorder patients.

Inclusion Criteria:

  • Healthy group
  • Parkinson's disease
  • Major depressive disorder
  • All participants will be competent and willing to give written informed consent. Patients over 65 and/or suspected to have a cognitive decline will be tested by the Mini-mental test and will be included in the study only if the score is above 26.

Exclusion Criteria:

  • Non-competent or unable to give written informed consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01512732

Layout table for location contacts
Contact: Renana Eitan, Dr 972-050-4048165

Layout table for location information
Hadassah Medical Organization,
Jerusalem,, Israel
Contact: Hadas Lemberg, PhD    00 972 2 6777572   
Principal Investigator: Renana Eitan, MD         
Sponsors and Collaborators
Hadassah Medical Organization

Layout table for additonal information
Responsible Party: Hadassah Medical Organization Identifier: NCT01512732    
Other Study ID Numbers: HebVerMAV-HMO-CTIL
First Posted: January 19, 2012    Key Record Dates
Last Update Posted: January 24, 2012
Last Verified: January 2012
Additional relevant MeSH terms:
Layout table for MeSH terms
Parkinson Disease
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases